Fernyhough Paul

Dr. Fernyhough performed his PhD in biochemistry in the department of Biochemistry at University of Sheffield in the UK. He also performed postdoctoral research at Colorado State University, Kings College London and as a Wellcome Trust Postdoctoral Fellow at St Bartholomew’s Medical College. Dr. Fernyhough subsequently worked for 5½ years (1998-2004) as a tenured lecturer in the School of Biological Sciences (now the Faculty of Life Sciences) at the University of Manchester. Dr. Fernyhough came to Winnipeg in 2004 and has helped to set up a neuroscience research group at St Boniface Hospital Albrechtsen Research Centre with strong links with the Department of Pharmacology & Therapeutics at the University of Manitoba. Dr. Fernyhough’s general research interest is in the cell biology underlying neurodegenerative disorders of the peripheral and central nervous systems with a focus on the impact of diabetes. Commercialization is proceeding in the area of therapeutics for peripheral neuropathy. A small biotech start-up, WinSanTor Inc, has been established and is directing phase 2 clinical trials in diabetic neuropathy and in the future chemotherapy-induced peripheral neuropathy. For his sins he is a life-long supporter of West Ham United football team.